ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE
2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE for head and neck neoplasms | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| ZI-MA4-1 (TCR-NK cells) + Cyclophosphamide + FLUDARABINE for sarcoma, synovial | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |